UTI director buys 1,000 shares at $21.80 each

UNIVERSAL TECHNICAL INSTITUTE INC (UTI) director Robert Thomas Devincenzi purchased 1,000 shares of common stock on 2026-08-27 in an open-market or private transaction.

Rhea-AI Filing Summary

UNIVERSAL TECHNICAL INSTITUTE INC (UTI) director Robert Thomas Devincenzi purchased 1,000 shares of common stock on 2026-08-27 in an open-market or private transaction. The weighted-average purchase price was $21.80 per share, with individual trades executed between $21.75 and $21.85. Following this transaction, he directly owns 151,330 shares of UTI common stock.

Insider Trade Summary

Net Buyer: 1,000 shares

Net Buy 1 txn

Insider DEVINCENZI ROBERT THOMAS

Role Director

Bought 1,000 shs ($22K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, $0.0001 par value F1	1,000	$21.80	$22K

Holdings After Transaction: Common Stock, $0.0001 par value — 151,330 shares (Direct)

Footnotes (1)

1. F1. The prices reported in Column 4 reflect a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.75 to $21.85. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Key Figures

Shares purchased: 1,000 shares of Common Stock Weighted-average purchase price: $21.80 per share Purchase price range: $21.75 to $21.85 per share +1 more

4 metrics

Shares purchased 1,000 shares of Common Stock Open-market or private purchase on 2026-08-27

Weighted-average purchase price $21.80 per share Price for 1,000-share purchase on 2026-08-27

Purchase price range $21.75 to $21.85 per share Multiple transactions underlying the weighted-average price

Shares owned after transaction 151,330 shares Direct ownership of UTI common stock following the reported purchase

Key Terms

weighted average price, open market or private transaction, Common Stock, $0.0001 par value

3 terms

weighted average price financial

"The prices reported in Column 4 reflect a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"transaction code description: Purchase in open market or private transaction"

Common Stock, $0.0001 par value financial

"security_title: Common Stock, $0.0001 par value"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UTI report for Robert Thomas Devincenzi?

Robert Thomas Devincenzi, a director of UTI, purchased 1,000 shares of common stock on 2026-08-27 in an open-market or private transaction at a $21.80 weighted-average price per share, with trades between $21.75 and $21.85.

At what price did the UTI director buy shares in this Form 4 filing?

The UTI director bought shares at a weighted-average price of $21.80 per share. According to the filing, the purchases occurred in multiple trades at prices ranging from $21.75 to $21.85 per share.

How many UTI shares does Robert Thomas Devincenzi own after this transaction?

After the 1,000-share purchase reported on 2026-08-27, Robert Thomas Devincenzi directly owns 151,330 shares of UTI common stock as reported in the Form 4.

Was the UTI insider transaction made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, indicating the reported 1,000-share purchase was not affirmed as being made pursuant to a Rule 10b5-1 trading plan.

What type of security did the UTI director purchase in this Form 4?

The director purchased Common Stock, $0.0001 par value of UNIVERSAL TECHNICAL INSTITUTE INC, totaling 1,000 shares in this reported transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 08:00 PM EDT Accepted by SEC EDGAR 08/31/2026 - 08:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEVINCENZI ROBERT THOMAS

(Last) (First) (Middle)

4225 E. WINDROSE DRIVE, SUITE 200

(Street)

PHOENIX ARIZONA 85032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL TECHNICAL INSTITUTE INC [ UTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	08/27/2026		P		1,000	A	$21.8(1)	151,330	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The prices reported in Column 4 reflect a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.75 to $21.85. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

	/s/ Christopher Kevane, Attorney-in-Fact for Robert T. DeVincenzi	08/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)